Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal mucosal surface and gut microbiota ecosystem is a complex, dynamic interface consisting of the intestinal epithelium, the protective mucus layer, and a vast community of trillions of microorganisms including bacteria, viruses, and fungi (Lynch & Pedersen, 2016). This ecosystem is fundamental to human health, performing essential roles in nutrient digestion, vitamin synthesis, and the education of the host immune system to maintain self-tolerance while defending against pathogens (Belkaid & Hand, 2014). It acts as a semi-permeable barrier that regulates the passage of molecules from the gut lumen into the systemic circulation. Dysfunction or imbalance within this ecosystem, termed dysbiosis, is a primary driver in the pathogenesis of gastrointestinal disorders like Inflammatory Bowel Disease (IBD) and systemic conditions such as metabolic syndrome and certain cancers (NIH, 2023). In drug development, this system is targeted not as a single molecule but as a collective biological unit; therapies such as live biotherapeutics (e.g., SER-109), prebiotics, and targeted antibiotics aim to restore ecological balance and barrier function (FDA, 2023). Understanding the cross-talk between microbial metabolites and host receptors is a frontier in precision medicine, offering opportunities to modulate systemic inflammation and metabolic health through the gut environment.
Modulation of microbial composition to restore commensal populations, competitive inhibition of pathogenic colonization, enhancement of mucosal barrier integrity through tight junction regulation, and metabolic reprogramming of the host via microbial metabolites such as butyrate (Lynch & Pedersen, 2016; Belkaid & Hand, 2014).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucosal surface and gut microbiota ecosystem.